Using preclinical models, including human iPSC-derived microglia, and CSF from LRRK2-PD patients, we establish the functional relevance of LRRK2-mediated effects on lysosomal homeostasis by demonstrating that LRRK2 modulates BMP and GSL levels in the CNS. This evidence concerns the gene LRRK2 and Parkinson disease.